FDA

Health and Human Services Secretary Robert F. Kennedy Jr. faces scrutiny over federal budget cuts as a cyclospora outbreak sickens thousands across the country

The Pharmacy Compounding Advisory Committee voted 9-4 to add 20 peptide substances to the permitted compounding list, overriding internal FDA safety warnings.

Lilly's triple-receptor weight-loss drug retatrutide heads to FDA with a 24 percent efficacy edge over rivals and a $1,200 price target from JPMorgan.

The nation's highest court faces a critical decision on mail-order abortion pills, potentially reshaping the pharmaceutical market and igniting a new wave of political spending.